Quentin Lecocq (Q Lecocq)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Metastatic Breast Cancer

Capillary Electrophoresis

Top Venues

EJNMMI research

Pharmaceuticals (Basel, Switzerland)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot, Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular cancer therapeutics 21 (7) (2022)
Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, Lien De Beck, Thomas Ertveldt, Yannick De De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer. EJNMMI research 11 (1) (2021)
Dora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, Karine Breckpot, Nick Devoogdt, Marleen Keyaerts, Vicky Caveliers, Catarina Xavier, Jessica Bridoux
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine Chemistry. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, Maarten Dewilde, Sabrina Rizzolio, Quentin Lecocq, Evangelia Bolli, Ana Rita Santos, Damya Laoui, Steve Schoonooghe, Luca Tamagnone, Cleo Goyvaerts, Massimiliano Mazzone, Karine Breckpot, Jo A Van Ginderachter
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development. Cancers 12 (12) (2020)
Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt, Christian Vanhove, Karine Breckpot, Nick Devoogdt, Vicky Caveliers, Marleen Keyaerts, Catarina Xavier
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation. Biomolecules 10 (10) (2020)
Janik Puttemans, Yana Dekempeneer, Jos L Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Alfred Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies. Cancers 12 (4) (2020)
Quentin Lecocq, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm. International journal of molecular sciences 22 (1) (2020)